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IL-6 is produced by APCs such as macrophages, dendritic cells, and B cells, but also by nonhematopoietic cells (e.g., epithelial and endothelial cells, astrocytes, and fi broblasts) in response to external stimuli such as TNF-␣ , IL-1 ␤ , plateletderived growth factor, or bacterial and fungal components. It binds to a receptor complex consisting of the specifi c IL-6R ␣ and the gp130 signal transducing unit that activates the transcription factor STAT3, among other signaling molecules. IL-6 is a pleiotropic cytokine that plays an important role in acute-phase protein synthesis, bone metabolism, central nervous system function, growth and drug response of tumors, and the immune response (for reviews see references 1, 2 ). Regarding its function in the immune system, IL-6 is now thought of as an important link between innate and adaptive immunity, mediating several aspects of B and T cell responses ( 3 ) .
The role of IL-6 in CD4 + T cell function is multifaceted. IL-6 infl uences T cell eff ector functions by promoting Th2 cell diff erentiation through up-regulation of NFATc2 and c-maf ( 4, 5 ) . It also blocks IFN-␥ signaling through increased expression of silencer of cytokine signaling 1, thereby inhibiting Th1 cell diff erentiation ( 5 ) . In the presence of TGF-␤ , IL-6 promotes Th17 cell diff erentiation through STAT3-mediated up-regulation of the transcription factor retinoic acid receptor-related orphan receptor ␥ t ( 6 -10 ) . Although some of the molecular mechanisms used by IL-6 to mediate these diff erent responses are known, it is still unclear how these various eff ects on CD4 + T cells are orchestrated.
IL-6 was initially characterized as a factor that enhances antibody production in a B cell line ( 11 ) , and overexpression of IL-6 in mice causes Interleukin (IL) 6 is a proinfl ammtory cytokine produced by antigen-presenting cells and nonhematopoietic cells in response to external stimuli. It was initially identifi ed as a B cell growth factor and inducer of plasma cell differentiation in vitro and plays an important role in antibody production and class switching in vivo. However, it is not clear whether IL-6 directly affects B cells or acts through other mechanisms. We show that IL-6 is suffi cient and necessary to induce IL-21 production by naive and memory CD4 + T cells upon T cell receptor stimulation. IL-21 production by CD4 + T cells is required for IL-6 to promote B cell antibody production in vitro. Moreover, administration of IL-6 with inactive infl uenza virus enhances virus-specifi c antibody production, and importantly, this effect is dependent on IL-21. Thus, IL-6 promotes antibody production by promoting the B cell helper capabilities of CD4 + T cells through increased IL-21 production. IL-6 could therefore be a potential coadjuvant to enhance humoral immunity.
when using a twofold threshold on the probe set intensity ratio, IL-6 treated to untreated ( Fig. 1 B ; and Fig. S1 and Table  S1 , available at http://www.jem.org/cgi/content/full/jem .20081571/DC1). The microarray results were validated by real-time RT-PCR of several genes positively or negatively aff ected by the IL-6 treatment ( Fig. S2) .
Among the 132 genes whose expression was aff ected by IL-6, the cytokine IL-21 was especially remarkable, with a > 200-fold induction in CD4 + T cells activated in the presence of IL-6. The induction of IL-21 by IL-6 was confi rmed by real-time RT-PCR using RNA from CD4 + T cells activated for 16 h ( Fig. 1 C ) . Similar results were obtained by ELISA, where IL-21 production could only be detected in the presence of IL-6 ( Fig. 1 D ) . Although IL-6 has been shown to induce the expression of IL-4 and IL-17 ( 7, 8, 10, 22 ) , their expression was not increased by IL-6 stimulation early during activation. These results also confi rm a recent study showing that induction of IL-21 by IL-6 is independent of TGF-␤ stimulation and Th17 cell diff erentiation ( 23 ) . Moreover, among known cytokines IL-21 is the most potently induced one by IL-6 early during the activation of CD4 + T cells, as indicated by its high up-regulation, especially when compared with other soluble factors (Table S1 ).
IL-6 is required for IL-21 expression in CD4 T cells upon TCR stimulation
Given the high induction of IL-21 by IL-6, we examined whether other cytokines have a similar eff ect. CD4 + T cells were activated in the presence of IL-4, IL-12, or IFN-␥ , but none of those cytokines were able to promote IL-21 production ( Fig. 2 A ) . Neither growth and survival factors such as IL-2 and IL-7 ( Fig. 2 A and not depicted) nor other proinfl ammatory cytokines such as TNF-␣ and IL-1 were able to up-regulate IL-21 production ( Fig. 2 A and not depicted). IL-11, another cytokine that signals through gp130 ( 1 ), also failed to promote IL-21 production ( Fig. S3 , available at http://www.jem.org/ cgi/content/full/jem.20081571/DC1). Moreover, IL-6 is a very effi cient inducer of IL-21 expression, as a dose -response analysis revealed that IL-6 levels as low as 0.3 -0.8 ng/ml were able to readily induce measurable IL-21 production ( Fig. 2 B ) .
To determine whether IL-6 was required for IL-21 production by CD4 + T cells, spleen cells from wild-type or IL-6 Ϫ / Ϫ mice were treated with LPS, and the conditioned media were added to CD4 + T cells activated with anti-CD3 and anti-CD28 mAbs. Only CD4 + T cells activated in the presence of the LPSconditioned media from wild-type splenocytes expressed IL-21, whereas this expression was abrogated in the presence of a neutralizing anti -IL-6 mAb ( Fig. 2 C ) . In addition, conditioned media from IL-6 Ϫ / Ϫ splenocytes stimulated with LPS did not promote IL-21 expression ( Fig. 2 C ) . As a control, LPS alone added to activated CD4 + T cells did not induce IL-21 expression ( Fig. 2 C ) . Thus, APC-derived IL-6 is required for IL-21 production by CD4 + T cells upon activation in vitro. To show that IL-6 is required for IL-21 expression in vivo, IL-6 Ϫ / Ϫ and wild-type mice were immunized with OVA, and CD4 + T cells were analyzed for IL-21 production by ELISPOT analysis.
plasmocytosis, suggesting that IL-6 can promote the diff erentiation of B cells into plasma cells ( 12 ) . Likewise, IL-6 -defi cient mice show reduced antigen-specifi c IgG1, IgG2a, and IgG3 levels upon immunization with a T cell -dependent antigen, although IgM levels were not aff ected ( 13 ) . Further evidence for a role of IL-6 in IgG production has come from experiments using a transgenic mouse expressing a truncated form of gp130. These mice are unable to activate STAT3 upon IL-6 exposure and show reduced levels of most antibody isotypes after immunization with a T-dependent antigen ( 14 ) . However, expression of the transgene is not restricted to B cells, leaving open the possibility that other cells may require a functional gp130 receptor. Likewise, B cell -specifi c deletion of STAT3 results in impaired plasma cell diff erentiation and diminished antibody responses ( 15 ) , but this transcription factor is also activated by other cytokines.
The cytokine IL-21 has been shown to play a major role in antibody production by promoting the diff erentiation of B cells into plasma cells both in mice and humans ( 16, 17 ) . Accordingly, IL-21 promotes the production of IgG1, IgG2a, and IgG3, but it has an inhibitory eff ect on IgE production ( 18 ) . The inhibition of IgE is mediated by IL-21 -induced up-regulation of Id2 that negatively regulates class switching to IgE ( 19 ) . Similar to IL-6, IL-21 activates predominantly STAT3, but through binding to its specifi c receptor and the common ␥ chain signal transducing unit that it shares with other members of the IL-2 family of cytokines ( 20 ) . In B cells, IL-21 -induced STAT3 activation down-regulates B cell lymphoma 6 and upregulates expression of B lymphocyte -induced maturation protein 1, thereby promoting plasma cell diff erentiation ( 21 ) .
In this report, we identify IL-21 as the only cytokine that is specifi cally induced in CD4 + T cells by IL-6 early upon antigen stimulation. IL-6 is necessary to mediate IL-21 production in naive CD4 + T cells during antigen stimulation. Furthermore, we show that IL-6 promotes antibody production in B cells indirectly by up-regulation of IL-21 expression in CD4 + T cells and that this IL-21 then acts on B cells.
RESULTS AND DISCUSSION Regulation of early gene expression by IL-6 during the activation of CD4 + T cells
IL-6 has been associated with diff erent aspects of T cell activation, diff erentiation, and survival ( 2 ). However, little is known about the changes in gene expression induced by IL-6 stimulation early during T cell activation. To further characterize early eff ects of IL-6 on CD4 + T cells, we performed microarray analysis. Sorted CD4 + NK1.1 Ϫ T cells were activated with anti-CD3 and anti-CD28 mAbs in the absence or presence of IL-6 for 16 h. For each condition, three independent preparations of RNA were used for hybridization of gene arrays. For analysis of microarray data, we explored the use of the 1% contour on the joint distribution of fold change and p-value derived from sample label permutations ( Fig. 1 A ) , which resulted in signifi cance at P = 0.1, as well as identifi cation of 343 genes, with a false discovery rate of 13%. 132 differentially regulated genes (190 probe sets) were found BRIEF DEFINITIVE REPORT tion in vitro and in vivo . Although a recent paper reported that IL-21 can induce its own expression through STAT3 ( 24 ), our results indicate that the initial IL-21 expression in CD4 + T cells is mediated by IL-6.
The number of IL-21 -producing CD4 + T cells was severely impaired in IL-6 Ϫ / Ϫ compared with wild-type mice ( Fig. 2 D ) . Collectively, these results demonstrate that IL-6 is required for the production of IL-21 by CD4 + T cells upon antigen stimula-
Figure 1. Effects of IL-6 on the gene expression profi le of CD4 + T cells early during activation. (A) FACS-sorted CD4 + T cells were activated with
anti-CD3 and anti-CD28 in the absence or presence of IL-6 for 16 h. The gene expression profi le from total RNA was examined by Affymetrix GeneChip analysis. In the volcano plot, open circles represent probe sets for which expression is changed more than twofold up or down after IL-6 treatment, whereas dots represent all other probe sets. The number of genes exceeding the threshold was the largest among the 10 datasets obtained by permutation of sample labels, yielding statistical signifi cance of differential expression at P = 0.1 (the minimum value) and a false discovery rate < 19% (the minimum being 10%). The blue line encloses 99% of the probe sets under the null hypothesis, obtained by permutation of sample labels. The IL-21 gene is marked with an arrow. (B) Heat maps representing the relative expression of genes among IL-6 -treated and control samples. Genes were sorted within each group based on their fold change (top, highest fold induction; bottom, highest fold down-regulation). Expression statistics for each gene were centered, scaled, and mapped to a color scale. Red represents relatively low expression, whereas green represents relatively high expression. (C) Cells were purifi ed and activated as in A, and IL-21 expression was measured by quantitative real-time RT-PCR. The means ± SEM of three experiments are shown. (D) CD4 + T cells were activated with anti-CD3 and anti-CD28 mAbs in the absence or presence of IL-6 for the indicated periods of time. Cell-culture supernatants were analyzed for IL-21 production by ELISA. The means ± SEM of four experiments are shown. 
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IL-21 expression was similar to other eff ector cytokines upregulated early in memory CD4 + T cells, sorted CD4 + CD44 high T cells were stimulated with anti-CD3 and anti-CD28 mAbs in the absence or presence of IL-6. As expected, memory CD4 + T cells expressed relatively high levels of IFN-␥ and IL-4 regardless of the presence of IL-6 ( Fig. 2 G ) . However, similar to naive CD4 + T cells, memory cells did not produce IL-21 in the absence of IL-6 but did have high levels of expression when IL-6 was present ( Fig. 2 G ) . Thus, production of IL-21 by naive and memory CD4 + T cells upon antigen stimulation requires the presence IL-6.
Induction of antibody production by IL-6 requires up-regulation of IL-21 expression in CD4 + T cells
Both IL-6 and IL-21 have been shown to promote antibody production by B cells. Several studies demonstrated a direct eff ect of IL-21 on plasma cell diff erentiation through up-regulation of IL-21 has been shown to be produced by diff erentiated Th2 and Th17 eff ector CD4 + T cells upon restimulation as well as by NKT cells ( 25 -29 ) . To further demonstrate the direct eff ect of IL-6 on IL-21 production by naive CD4 + T cells, we activated sorted CD4 + CD44 low NK1.1 Ϫ T cells in the presence or absence of IL-6. IL-21 expression was essentially undetectable in purifi ed naive CD4 + T cells activated in the absence of IL-6 even after 3 d of stimulation ( Fig. 2 E ) . In contrast, high IL-21 expression could be detected in activated naive CD4 + T cells treated with IL-6 as soon as 24 h after initial stimulation ( Fig. 2 E ) . Similarly, naive CD4 + T cells from AND TCR transgenic mice (recognizing pigeon cytochrome c [cyt c]) produce IL-21 only in the presence of IL-6 upon stimulation with cyt c peptide and APCs ( Fig. 2 F ) .
Memory CD4 + T cells are known for their ability to produce high amounts of eff ector cytokines such as IFN-␥ and IL-4 rapidly after antigen stimulation ( 30 ) . To test whether IL-6 Ϫ / Ϫ mice, because IL-6 is known to be also produced by B cells. In the absence of IL-6, IgG1 levels were practically undetectable ( Fig. 3 D ) . IL-6 strongly increased IgG1 production when B cells were cultured together with CD4 + T cells from wild-type mice but failed to induce IgG1 in the presence of IL-21 Ϫ / Ϫ CD4 + T cells ( Fig. 3 D ) . Thus, the effect of IL-6 on antibody production appears to be dependent on IL-21 produced by CD4 + T cells. Addition of exogenous IL-21 could compensate for IL-21 defi ciency, indicating that IL-21 Ϫ / Ϫ CD4 + T cells are functional despite their lack of IL-21 production ( Fig. 3 D ) .
In addition to its eff ects on B cells, IL-21 has been shown to promote Th2 cell diff erentiation by inhibiting Th1 cell diff erentiation ( 25 ) . It can also induce Th17 cell diff erentiation when TGF-␤ is present ( 27 -29 ) . To exclude that IL-6induced IL-21 promoted antibody production through its eff ect on the diff erentiation of CD4 + T cells rather than acting directly on B cells, we activated wild-type CD4 + T cells with anti-CD3 mAb and co-cultured them in the presence of B cells from wild-type and IL-21R Ϫ / Ϫ mice. IL-6 augmented IgG1 production in wild-type B cells compared with the medium control ( Fig. 3 E ) . In contrast, B cells that were deficient for IL-21R did not produce IgG1 when stimulated with IL-6 despite co-cultured CD4 + T cells that were capable of receiving IL-21 signals ( Fig. 3 E ) . Accordingly, IL-21 promoted the transcription factor B lymphocyte -induced maturation protein 1 ( 16, 17, 21 ) . Although in vitro experiments using T -B cell co-culture and in vivo studies indicate that IL-6 is required for antibody production ( 13 ) , the molecular mechanism remains unknown, and it is unclear whether this is a direct eff ect on B cells. Because IL-6 promotes IL-21 production by CD4 + T cells, it was possible that these two pathways are closely linked to provide T cell help to B cells. The analysis of antibody production in vitro with wild-type or IL-6 Ϫ / Ϫ total spleen cells activated with anti-CD3 mAb confi rmed the contribution of IL-6 to IgG1 production ( Fig. 3 A ) . However, analysis of IL-6R ␣ cell-surface expression showed that resting splenic B cells had almost undetectable levels, whereas it was present on a substantial fraction of CD4 + T cells ( Fig. 3 B ) . In contrast, IL-21R expression could be detected on B cells as well as CD4 + T cells, in accordance with a previous paper ( 20 ) . In addition, IL-21 promoted IgG1 production in total splenocytes from IL-6 Ϫ / Ϫ mice activated with anti-CD3 mAb, similar to IL-6 ( Fig. 3 C ) . Collectively, these results suggest that IL-6 mediates antibody production by inducing IL-21 expression in CD4 + T cells. To test for this possibility, we established a co-culture of CD4 + T cells activated with anti-CD3 mAb and B cells in the presence of exogenous IL-6. CD4 + T cells were isolated from wild-type and IL-21 Ϫ / Ϫ mice, whereas B cells were obtained from 
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signals to B cells. In contrast, the presence of IL-6 during immunization substantially enhanced the levels of infl uenzaspecifi c IgG1 ( Fig. 4 A ) . Thus, IL-6 enhances the in vivo antibody response.
To determine whether the eff ect of IL-6 on in vivo antiviral antibody response is also dependent on IL-21, we immunized wild-type and IL-21 Ϫ / Ϫ mice with inactive infl uenza virus in the presence or absence of IL-6. Infl uenza-specifi c IgM levels were comparable in IL-21 Ϫ / Ϫ and wild-type mice ( Fig. 4 B ) , in agreement with previous studies showing independence of IgM from IL-21 ( 18 ) . In contrast, IL-6 promoted the production of IgG1 in wild-type mice, but it had no eff ect in IL-21 Ϫ / Ϫ mice ( Fig. 4 B ) . Collectively, these results show that administration of IL-6 enhances antibody response, but this eff ect is dependent on endogenous IL-21 production.
Role of IL-21 and IL-6 in antibody response to infl uenza infection
Despite the established role of IL-21 in generation of plasma cells and antibody production, it remains unknown whether IL-21 plays a role in antibody response during infl uenza infection or any other viral infection. We therefore examined IgG1 production only when IL-21R was present on B cells but not in IL-21R Ϫ / Ϫ B cells, suggesting that IL-21 induced by IL-6 acted directly on B cells to increase IgG1 levels ( Fig. 3 E ) . These results show that IL-6 can promote antibody production by inducing IL-21 expression in CD4 + T cells, and IL-21 subsequently acts on B cells.
Administration of IL-6 during infl uenza immunization promotes specifi c IgG production through IL-21
The indirect eff ect of IL-6 on antibody production through IL-21 generated by CD4 + T cells suggested that IL-6 could be a potent enhancer of the humoral immune response, because small amounts of IL-6 could result in an increased and prolonged production of IL-21, which would increase antibody production by B cells. We therefore investigated whether administration of IL-6 during viral immunization could boost the antiviral specifi c antibody response. We immunized wildtype mice with inactive PR8 infl uenza virus (in the absence of adjuvant) in combination with IL-6 or PBS, and analyzed virus-specifi c antibody production. Infl uenza-specifi c IgM serum levels were not aff ected by the administration of IL-6 ( Fig. 4 A ) , indicating that IL-6 did not provide overall survival . (B -D) Wild-type and IL-6 Ϫ / Ϫ mice were infected i.n. with a sublethal dose (0.05 LD 50 ) of active PR8 virus. Animals were monitored daily, and the time to death was recorded as the day after infection. Kaplan-Meier survival curves were generated using Prism 4.03 software (GraphPad Software, Inc.), and the log-rank test was used to determine the signifi cance of differences between the strains (B). Weight was also measured daily in the surviving mice. The percentage of the initial weight is shown (C). Serum levels of virus-specifi c IgG1 were determined in the surviving mice (six out of six for wild-type mice and two out of six for IL-6 Ϫ / Ϫ mice) 14 d after infection (D). Data represent groups of fi ve (A) or six (B -D) mice from one experiment out of two performed. Error bars indicate SD.
MATERIALS AND METHODS Mice
B10.BR and C57BL/6J mice (The Jackson Laboratory) were housed under sterile conditions at the animal care facility at the University of Vermont and used for experiments between 8 and 14 wk of age. IL-21 gene -defi cient mice were obtained from the Mutant Mouse Regional Resource Center at the University of California, Davis, and were backcrossed to C57BL/6J. TCR transgenic AND mice specifi c for pigeon cyt c, as well as IL-6 and IL-21R gene -defi cient mice, as previously described ( 18, 33, 34 ) . Immunizations were performed with UV-inactivated A/PR/8/34 (PR8) infl uenza A virus (H1N1) injected s.c. together with 500 ng recombinant IL-6 (R & D Systems), as indicated in the fi gures. For live infections, mice were inoculated intranasally (i.n.) during light isofl urane anesthesia with 0.05 or 0.1 LD 50 (2.5 or 5 × 10 3 egg infectious units/ml) of PR8 virus in 100 μ l PBS. Procedures that involved mice were approved by the Institutional Animal Care and Use Committees from the University of Vermont and the Trudeau Institute.
Cell preparation and activation
CD4 + T cells from lymph nodes and spleens were isolated by negative selection, as previously described ( 35 ) , depleting cells expressing CD8, CD11b, MHC class II, and NK1.1. For FACS isolation, negatively selected CD4 + T cells were stained with anti-CD4 -PE -Cy5.5, anti-NK1.1 -PE, and anti-CD25 -FITC plus anti-CD44 -allophycocyanin (BD) and sorted on a FACSAria (BD) by gating in the low forward scatter and low side scatter lymphocyte population. Antibodies against B220, CD19, IL-6R ␣ (BD), and IL-21R (eBioscience) were also used for fl ow cytometry.
CD4 + T cells were activated with plate-bound 5 μ g/ml anti-CD3 (2C11) and 1 μ g/ml of soluble anti-CD28 (BD) mAbs in Bruff ' s medium in the presence or absence of diff erent cytokines: 10 ng/ml TNF-␣ , 20 ng/ml IL-1 ␣ , 50 U/ml IL-2, 10 3 U/ml IL-4, 100 ng/ml IL-6, 3.5 ng/ml IL-12, 10 ng/ml IFN-␥ (all obtained from R & D Systems), 100 ng/ml IL-11 (Genetics Institute), 100 ng/ml IL-21 (PeproTech), or 10 ng/ml LPS (Sigma-Aldrich).
B cells were purifi ed by positive selection using anti-CD19 MACS beads (Miltenyi Biotec) according to the manufacturer ' s instructions and were generally > 95% CD19 + B220 + . For co-culture experiments, CD4 + T cells were stimulated with 5 μ g/ml of plate-bound anti-CD3 (2C11) and mixed with B cells in a 1:3 T/B cell ratio.
ELISAs
For IL-21 detection, the mouse-specifi c IL-21 DuoSet kit was used according to the manufacturer ' s protocol (R & D Systems). IgG1 levels were determined with anti -mouse IgG1 as capture antibody and horseradish peroxidase (HRP)conjugated anti -mouse IgG1 as detection antibody, with mouse IgG1 as standard (all obtained from SouthernBiotech). Infl uenza-specifi c antibody isotypes were determined using UV-inactivated infl uenza PR8 as antigen. Antibody levels in serially diluted serum samples were analyzed with HRP-conjugated antibodies specifi c for mouse IgM, IgG1, and IgG2c (SouthernBiotech).
ELISPOT assay
IL-21 -producing CD4 + T cells were detected according to a protocol adapted from a previously published paper ( 36 ) . In brief, CD4 + T cells were activated with anti-CD3 and anti-CD28 mAbs in the presence or absence of IL-6 or an anti -IL-6 mAb. After 45 h, cells were harvested and counted, and 10 4 cells per well were plated in anti -IL-21 -coated ELISPOT plates. Cells were incubated for 4 h in medium alone or medium containing 5 ng/ml PMA and 250 ng/ml ionomycin. Plates were developed as previously described ( 36 ) using a biotinylated anti -IL-21 mAb, and the total number of IL-21 -producing cells was determined in an ELISPOT reader (CTL-ImmunoSpot S5 ELISPOT reader; Cellular Technology Ltd.).
Analysis of RNA
Total RNA was extracted from cells by using the RNAeasy kit (QIAGEN) as recommended by the manufacturer. RNA was reverse transcribed into cDNA, as previously described ( 37 ) . mRNA levels were quantifi ed with a the contribution of endogenous IL-21 to the production of virus-specifi c antibodies in response to a sublethal dose (0.1 LD 50 ) of the live PR8 infl uenza virus using wild-type and IL-21 -defi cient mice. 14 d after infection, infl uenza-specifi c antibody titers in serum were determined. Infl uenza-specifi c IgG1 and IgG2c levels were severely reduced in infected IL-21 Ϫ / Ϫ mice compared with wild-type mice ( Fig. 5 A ) . Thus, IL-21 plays a role in antibody response to infl uenza. We also examined the contribution of endogenous IL-6 to the antibody production against infection with PR8 infection using IL-6 Ϫ / Ϫ mice. Interestingly, we found in repeated experiments that IL-6 -defi cient mice were highly susceptible to infl uenza virus infection, because a sublethal dose of live PR8 was suffi cient to cause a relatively high rate of mortality in these mice but not in wild-type mice ( Fig. 5 B ) , indicating that IL-6 is essential for protection against infl uenza virus. Unlike infected wild-type mice, infected IL-6 Ϫ / Ϫ mice could not recover the weight loss caused by the acute viral infection ( Fig. 5 C ) , suggesting that these mice could not clear or control the virus. Analysis of PR8-specifi c antibody production in the surviving IL-6 Ϫ / Ϫ mice showed a reduction in virus antibody titers ( Fig. 5 D ) . IL-6 is therefore a key cytokine for resolution of infl uenza virus infection.
In summary, we show that IL-6 is a very specifi c and effective inducer of IL-21 production by CD4 + T cells, and that it is suffi cient and required for IL-21 production by naive (and probably memory) CD4 + T cells upon antigen stimulation in vitro and in vivo . Although it was proposed that IL-21 is preferentially expressed by eff ector Th17 cells ( 24, 27 -29 ) , a recently published study ( 23 ) , as well as our results in this report, show that IL-6, in the absence of TGF-␤ , can induce the production of IL-21 in CD4 + T cells. IL-21 is also produced by the T follicular helper (Tfh) subset of CD4 + T cells that localizes in B cell follicles and provides help to B cells ( 31 ) . Because follicular dendritic cells produce signifi cant amounts of IL-6 ( 13 ), it is possible that the presence of IL-6 in follicles can contribute to the production of IL-21 by these Tfh cells. A study published at the time of submission of this manuscript supports the need of IL-6 for the generation of Tfh cells ( 32 ) .
Although IL-6 has been long considered as a B cell growth factor and mediator of plasma cell diff erentiation, our data in this report show the requirement of IL-21 for IL-6 to induce antibody production in vitro and in vivo. We propose that IL-6 enhances antibody production indirectly by acting on naive (and likely memory) antigen-specifi c CD4 + T cells to promote their diff erentiation into Tfh cells that produce high levels of IL-21. Accordingly, we also show that both IL-6 and IL-21 play a role in the immune response during infl uenza infection, and administration of IL-6 during viral immunization substantially increased virusspecifi c antibody response without the need of additional coadjuvants, but in an IL-21 -dependent manner. The use of IL-6 as coadjuvant during immunization may therefore be a promising tool to achieve successful vaccination against specifi c pathogens whose clearance is highly dependent on humoral immunity.
